Radiotherapy radiation will activate the immune system, and the expression of PD-L2/PD-L1 will increase in some tumor patients, so radiotherapy combined with anti-PD-L1/PD-L2 therapy will improve the tumor treatment effect to some extent. The gene discussed is PDCD1LG2; the disease is neoplasm.